Request for Covid-19 Impact Assessment of this Report
The United States Mefoxin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mefoxin market, reaching US$ million by the year 2028. As for the Europe Mefoxin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Mefoxin players cover Merck KGaA, GSK, CJ CheilJedang, and Chong Kun Dang, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mefoxin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.98
0.9
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Haemophilus Influenzae
Neisseria Gonorrhoeae
Lyme Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck KGaA
GSK
CJ CheilJedang
Chong Kun Dang
Astellas
Sandoz
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mefoxin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Mefoxin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Mefoxin by Country/Region, 2017, 2022 & 2028
2.2 Mefoxin Segment by Type
2.2.1 0.98
2.2.2 0.9
2.3 Mefoxin Sales by Type
2.3.1 Global Mefoxin Sales Market Share by Type (2017-2022)
2.3.2 Global Mefoxin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Mefoxin Sale Price by Type (2017-2022)
2.4 Mefoxin Segment by Application
2.4.1 Haemophilus Influenzae
2.4.2 Neisseria Gonorrhoeae
2.4.3 Lyme Disease
2.4.4 Others
2.5 Mefoxin Sales by Application
2.5.1 Global Mefoxin Sale Market Share by Application (2017-2022)
2.5.2 Global Mefoxin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Mefoxin Sale Price by Application (2017-2022)
3 Global Mefoxin by Company
3.1 Global Mefoxin Breakdown Data by Company
3.1.1 Global Mefoxin Annual Sales by Company (2020-2022)
3.1.2 Global Mefoxin Sales Market Share by Company (2020-2022)
3.2 Global Mefoxin Annual Revenue by Company (2020-2022)
3.2.1 Global Mefoxin Revenue by Company (2020-2022)
3.2.2 Global Mefoxin Revenue Market Share by Company (2020-2022)
3.3 Global Mefoxin Sale Price by Company
3.4 Key Manufacturers Mefoxin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mefoxin Product Location Distribution
3.4.2 Players Mefoxin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Mefoxin by Geographic Region
4.1 World Historic Mefoxin Market Size by Geographic Region (2017-2022)
4.1.1 Global Mefoxin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Mefoxin Annual Revenue by Geographic Region
4.2 World Historic Mefoxin Market Size by Country/Region (2017-2022)
4.2.1 Global Mefoxin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Mefoxin Annual Revenue by Country/Region
4.3 Americas Mefoxin Sales Growth
4.4 APAC Mefoxin Sales Growth
4.5 Europe Mefoxin Sales Growth
4.6 Middle East & Africa Mefoxin Sales Growth
5 Americas
5.1 Americas Mefoxin Sales by Country
5.1.1 Americas Mefoxin Sales by Country (2017-2022)
5.1.2 Americas Mefoxin Revenue by Country (2017-2022)
5.2 Americas Mefoxin Sales by Type
5.3 Americas Mefoxin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mefoxin Sales by Region
6.1.1 APAC Mefoxin Sales by Region (2017-2022)
6.1.2 APAC Mefoxin Revenue by Region (2017-2022)
6.2 APAC Mefoxin Sales by Type
6.3 APAC Mefoxin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mefoxin by Country
7.1.1 Europe Mefoxin Sales by Country (2017-2022)
7.1.2 Europe Mefoxin Revenue by Country (2017-2022)
7.2 Europe Mefoxin Sales by Type
7.3 Europe Mefoxin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mefoxin by Country
8.1.1 Middle East & Africa Mefoxin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Mefoxin Revenue by Country (2017-2022)
8.2 Middle East & Africa Mefoxin Sales by Type
8.3 Middle East & Africa Mefoxin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mefoxin
10.3 Manufacturing Process Analysis of Mefoxin
10.4 Industry Chain Structure of Mefoxin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mefoxin Distributors
11.3 Mefoxin Customer
12 World Forecast Review for Mefoxin by Geographic Region
12.1 Global Mefoxin Market Size Forecast by Region
12.1.1 Global Mefoxin Forecast by Region (2023-2028)
12.1.2 Global Mefoxin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mefoxin Forecast by Type
12.7 Global Mefoxin Forecast by Application
13 Key Players Analysis
13.1 Merck KGaA
13.1.1 Merck KGaA Company Information
13.1.2 Merck KGaA Mefoxin Product Offered
13.1.3 Merck KGaA Mefoxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck KGaA Main Business Overview
13.1.5 Merck KGaA Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Mefoxin Product Offered
13.2.3 GSK Mefoxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 CJ CheilJedang
13.3.1 CJ CheilJedang Company Information
13.3.2 CJ CheilJedang Mefoxin Product Offered
13.3.3 CJ CheilJedang Mefoxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CJ CheilJedang Main Business Overview
13.3.5 CJ CheilJedang Latest Developments
13.4 Chong Kun Dang
13.4.1 Chong Kun Dang Company Information
13.4.2 Chong Kun Dang Mefoxin Product Offered
13.4.3 Chong Kun Dang Mefoxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Chong Kun Dang Main Business Overview
13.4.5 Chong Kun Dang Latest Developments
13.5 Astellas
13.5.1 Astellas Company Information
13.5.2 Astellas Mefoxin Product Offered
13.5.3 Astellas Mefoxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Astellas Main Business Overview
13.5.5 Astellas Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Mefoxin Product Offered
13.6.3 Sandoz Mefoxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
14 Research Findings and Conclusion
Table 1. Mefoxin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Mefoxin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.98
Table 4. Major Players of 0.9
Table 5. Global Mefoxin Sales by Type (2017-2022) & (K MT)
Table 6. Global Mefoxin Sales Market Share by Type (2017-2022)
Table 7. Global Mefoxin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Mefoxin Revenue Market Share by Type (2017-2022)
Table 9. Global Mefoxin Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Mefoxin Sales by Application (2017-2022) & (K MT)
Table 11. Global Mefoxin Sales Market Share by Application (2017-2022)
Table 12. Global Mefoxin Revenue by Application (2017-2022)
Table 13. Global Mefoxin Revenue Market Share by Application (2017-2022)
Table 14. Global Mefoxin Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Mefoxin Sales by Company (2020-2022) & (K MT)
Table 16. Global Mefoxin Sales Market Share by Company (2020-2022)
Table 17. Global Mefoxin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Mefoxin Revenue Market Share by Company (2020-2022)
Table 19. Global Mefoxin Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Mefoxin Producing Area Distribution and Sales Area
Table 21. Players Mefoxin Products Offered
Table 22. Mefoxin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mefoxin Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Mefoxin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Mefoxin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Mefoxin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Mefoxin Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Mefoxin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Mefoxin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Mefoxin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Mefoxin Sales by Country (2017-2022) & (K MT)
Table 34. Americas Mefoxin Sales Market Share by Country (2017-2022)
Table 35. Americas Mefoxin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Mefoxin Revenue Market Share by Country (2017-2022)
Table 37. Americas Mefoxin Sales by Type (2017-2022) & (K MT)
Table 38. Americas Mefoxin Sales Market Share by Type (2017-2022)
Table 39. Americas Mefoxin Sales by Application (2017-2022) & (K MT)
Table 40. Americas Mefoxin Sales Market Share by Application (2017-2022)
Table 41. APAC Mefoxin Sales by Region (2017-2022) & (K MT)
Table 42. APAC Mefoxin Sales Market Share by Region (2017-2022)
Table 43. APAC Mefoxin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Mefoxin Revenue Market Share by Region (2017-2022)
Table 45. APAC Mefoxin Sales by Type (2017-2022) & (K MT)
Table 46. APAC Mefoxin Sales Market Share by Type (2017-2022)
Table 47. APAC Mefoxin Sales by Application (2017-2022) & (K MT)
Table 48. APAC Mefoxin Sales Market Share by Application (2017-2022)
Table 49. Europe Mefoxin Sales by Country (2017-2022) & (K MT)
Table 50. Europe Mefoxin Sales Market Share by Country (2017-2022)
Table 51. Europe Mefoxin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Mefoxin Revenue Market Share by Country (2017-2022)
Table 53. Europe Mefoxin Sales by Type (2017-2022) & (K MT)
Table 54. Europe Mefoxin Sales Market Share by Type (2017-2022)
Table 55. Europe Mefoxin Sales by Application (2017-2022) & (K MT)
Table 56. Europe Mefoxin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Mefoxin Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Mefoxin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Mefoxin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Mefoxin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Mefoxin Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Mefoxin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Mefoxin Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Mefoxin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Mefoxin
Table 66. Key Market Challenges & Risks of Mefoxin
Table 67. Key Industry Trends of Mefoxin
Table 68. Mefoxin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Mefoxin Distributors List
Table 71. Mefoxin Customer List
Table 72. Global Mefoxin Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Mefoxin Sales Market Forecast by Region
Table 74. Global Mefoxin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Mefoxin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Mefoxin Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Mefoxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Mefoxin Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Mefoxin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Mefoxin Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Mefoxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Mefoxin Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Mefoxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Mefoxin Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Mefoxin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Mefoxin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Mefoxin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Mefoxin Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Mefoxin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Mefoxin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Mefoxin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck KGaA Basic Information, Mefoxin Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck KGaA Mefoxin Product Offered
Table 94. Merck KGaA Mefoxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Merck KGaA Main Business
Table 96. Merck KGaA Latest Developments
Table 97. GSK Basic Information, Mefoxin Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Mefoxin Product Offered
Table 99. GSK Mefoxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. CJ CheilJedang Basic Information, Mefoxin Manufacturing Base, Sales Area and Its Competitors
Table 103. CJ CheilJedang Mefoxin Product Offered
Table 104. CJ CheilJedang Mefoxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. CJ CheilJedang Main Business
Table 106. CJ CheilJedang Latest Developments
Table 107. Chong Kun Dang Basic Information, Mefoxin Manufacturing Base, Sales Area and Its Competitors
Table 108. Chong Kun Dang Mefoxin Product Offered
Table 109. Chong Kun Dang Mefoxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Chong Kun Dang Main Business
Table 111. Chong Kun Dang Latest Developments
Table 112. Astellas Basic Information, Mefoxin Manufacturing Base, Sales Area and Its Competitors
Table 113. Astellas Mefoxin Product Offered
Table 114. Astellas Mefoxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Astellas Main Business
Table 116. Astellas Latest Developments
Table 117. Sandoz Basic Information, Mefoxin Manufacturing Base, Sales Area and Its Competitors
Table 118. Sandoz Mefoxin Product Offered
Table 119. Sandoz Mefoxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Sandoz Main Business
Table 121. Sandoz Latest Developments
List of Figures
Figure 1. Picture of Mefoxin
Figure 2. Mefoxin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mefoxin Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Mefoxin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Mefoxin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.98
Figure 10. Product Picture of 0.9
Figure 11. Global Mefoxin Sales Market Share by Type in 2021
Figure 12. Global Mefoxin Revenue Market Share by Type (2017-2022)
Figure 13. Mefoxin Consumed in Haemophilus Influenzae
Figure 14. Global Mefoxin Market: Haemophilus Influenzae (2017-2022) & (K MT)
Figure 15. Mefoxin Consumed in Neisseria Gonorrhoeae
Figure 16. Global Mefoxin Market: Neisseria Gonorrhoeae (2017-2022) & (K MT)
Figure 17. Mefoxin Consumed in Lyme Disease
Figure 18. Global Mefoxin Market: Lyme Disease (2017-2022) & (K MT)
Figure 19. Mefoxin Consumed in Others
Figure 20. Global Mefoxin Market: Others (2017-2022) & (K MT)
Figure 21. Global Mefoxin Sales Market Share by Application (2017-2022)
Figure 22. Global Mefoxin Revenue Market Share by Application in 2021
Figure 23. Mefoxin Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Mefoxin Revenue Market Share by Company in 2021
Figure 25. Global Mefoxin Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Mefoxin Revenue Market Share by Geographic Region in 2021
Figure 27. Global Mefoxin Sales Market Share by Region (2017-2022)
Figure 28. Global Mefoxin Revenue Market Share by Country/Region in 2021
Figure 29. Americas Mefoxin Sales 2017-2022 (K MT)
Figure 30. Americas Mefoxin Revenue 2017-2022 ($ Millions)
Figure 31. APAC Mefoxin Sales 2017-2022 (K MT)
Figure 32. APAC Mefoxin Revenue 2017-2022 ($ Millions)
Figure 33. Europe Mefoxin Sales 2017-2022 (K MT)
Figure 34. Europe Mefoxin Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Mefoxin Sales 2017-2022 (K MT)
Figure 36. Middle East & Africa Mefoxin Revenue 2017-2022 ($ Millions)
Figure 37. Americas Mefoxin Sales Market Share by Country in 2021
Figure 38. Americas Mefoxin Revenue Market Share by Country in 2021
Figure 39. United States Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Mefoxin Sales Market Share by Region in 2021
Figure 44. APAC Mefoxin Revenue Market Share by Regions in 2021
Figure 45. China Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Mefoxin Sales Market Share by Country in 2021
Figure 52. Europe Mefoxin Revenue Market Share by Country in 2021
Figure 53. Germany Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Mefoxin Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Mefoxin Revenue Market Share by Country in 2021
Figure 60. Egypt Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Mefoxin Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Mefoxin in 2021
Figure 66. Manufacturing Process Analysis of Mefoxin
Figure 67. Industry Chain Structure of Mefoxin
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...